Table 1. Baseline patient... | American Society of Hematology

Table 1.

Baseline patient characteristics

	Thal-Dex, N = 100			VAD, N = 100
	No. of patients	Mean ± SD	No. of patients	Mean ± SD	P
Age, y	—	54.01 ± 5.75	—	53.94 ± 5.47	NS
Stage I	12	—	12	—	—
Stage II + III	88	—	88	—	—
IgG, g/dL	61	4.45 ± 2.06	60	5.02 ± 1.84	NS
IgA, g/dL	26	4.35 ± 1.66	31	3.69 ± 1.38	NS
Hb, g/dL	—	11.01 ± 2.25	—	11.19 ± 2.00	NS
PLTs, × 10³	—	231.51 ± 79.14	—	233.30 ± 76.53	NS
BMPCs, %	—	52.39 ± 26.85	—	49.20 ± 26.25	NS
β₂-m, mg/L	—	3.66 ± 5.41	—	3.49 ± 5.34	NS

	Thal-Dex, N = 100			VAD, N = 100
	No. of patients	Mean ± SD	No. of patients	Mean ± SD	P
Age, y	—	54.01 ± 5.75	—	53.94 ± 5.47	NS
Stage I	12	—	12	—	—
Stage II + III	88	—	88	—	—
IgG, g/dL	61	4.45 ± 2.06	60	5.02 ± 1.84	NS
IgA, g/dL	26	4.35 ± 1.66	31	3.69 ± 1.38	NS
Hb, g/dL	—	11.01 ± 2.25	—	11.19 ± 2.00	NS
PLTs, × 10³	—	231.51 ± 79.14	—	233.30 ± 76.53	NS
BMPCs, %	—	52.39 ± 26.85	—	49.20 ± 26.25	NS
β₂-m, mg/L	—	3.66 ± 5.41	—	3.49 ± 5.34	NS

— indicates not applicable; NS, not significant; Hb, hemoglobin; PLTs, platelets; BMPCs, bone marrow plasma cells; and β₂-m, β₂-microglobulin.